Efalizumab/etanercept: First reports of cytomegalovirus infection: 2 case reports

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1228, 2008-01, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efalizumab/etanercept: Reactivation of latent tuberculosis (first report with efalizumab): case report

By  

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Etanercept/infliximab: Human papillomavirus infection (first report with etanercept) and molluscum contagiosum: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1198, 2008-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite

Ciclosporin: Cytomegalovirus infection: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1219, 2008-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Efalizumab withdrawal/etanercept: Erythrodermic flare of plaque psoriasis: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1220, 2008-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Adalimumab/efalizumab/etanercept/infliximab: Various toxicities: 19 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1387, 2012-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite